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Abstract
Background: Chagas disease is caused by Trypanosoma cruzi, a parasite endemic to Latin America. Most infections
occur in children by vector or congenital transmission. Trypanosoma cruzi establishes a complexity of specific
molecular parasite-host cell interactions to invade the host. However, most studies have been mainly focused on
the interaction between the parasite and different cell types, but not on the infection and invasion on a tissue level.
During congenital transmission, T. cruzi must cross the placental barrier, composed of epithelial and connective
tissues, in order to infect the developing fetus. Here we aimed to study the global changes of transcriptome in the
placental tissue after a T. cruzi challenge.
Results: Strong changes in gene expression profiling were found in the different experimental conditions, involving
the reprogramming of gene expression in genes involved in the innate immune response.
Conclusions: Trypanosoma cruzi induces strong changes in genes involved in a wide range of pathways, especially
those involved in immune response against infections.
Keywords: Trypanosoma cruzi, Placenta, Global gene expression, Microarray
Background
Chagas disease is a zoonotic disease caused by Trypano-
soma cruzi, a parasite endemic to Latin America. Most
infections occur in children by vector or congenital
transmission. The prevalence of Chagas disease in preg-
nant women in Latin America ranges between 5–40%
depending on the geographical area and the rate of con-
genital transmission is estimated to be 1–12% [1]. In
addition, due to population mobility, Chagas disease has
been increasingly detected in other non-endemic countries
and continents (where the vector does not exist) such as the
USA, Canada, Australia, Europe and Asia [2, 3]. Congenital
transmission, in spite of its low transmission rates, is par-
tially responsible for the progressive globalization of the dis-
ease [2, 4, 5]. Importantly, congenital infection is responsible
for an estimated 22% of new infections in 2010, making this
form of transmission epidemiologically relevant [6].
The parasite presents a complex life-cycle that occurs
in both vertebrate and invertebrate hosts, where three
major developmental stages are observed: epimastigotes,
trypomastigotes and amastigotes. Trypomastigotes con-
stitute the extracellular infective form in mammals
where they are able to infect a wide range of nucleated
mammalian cells [7]. Interestingly, T. cruzi has co-evolved
with mammals to establish a complexity of specific mo-
lecular parasite-host cell interactions to invade host cells
and tissues, to evade the host immune system and to
undergo intracellular replication [8]. Key steps in parasite
infection include its host cell penetration and replication
of the protozoa in the cytoplasm of infected cells. The ap-
plication of oligonucleotide and cDNA microarray tech-
nologies in the study of host-parasite interactions have
permitted rapid and unbiased examination of changes in
expression of a large number of genes at the level of tran-
scription [9, 10]. However, these studies have been mainly
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focused on the interaction between the parasite and differ-
ent cell types, but not on the infection and invasion on a
tissue level.
During congenital transmission, T. cruzi must cross the
placental barrier in order to infect the developing fetus
[3, 11]. This anatomical barrier is formed by the tropho-
blast, a two-layer epithelium which is in direct contact
with maternal blood, the fetal connective tissue (villous
stroma), the endothelium of fetal vessels and the basal
laminae that support the epithelia [3, 12]. Interestingly,
the congenital transmission rate for T. cruzi is low [4, 13]
and it has been proposed that the placenta might play an
important role avoiding parasite infection [3].
The study of gene expression profiles during infection
constitutes a very powerful tool to analyze global re-
sponses of several kinds of cells and tissues, allowing the
identification of new genes and/or pathways implicated
in the establishment of the infection and pathogenesis as
well as possible local tissue responses [3, 10]. Therefore,
here we aimed to study the global changes of transcrip-
tome in the placental tissue after T. cruzi challenge.
Methods
Parasite harvesting
Trypomastigotes from T. cruzi (Y Strain, T. cruzi II)
were obtained from previously infected Vero cells
(ATCC® CCL-81) grown in RPMI medium supplemented
with 5% fetal bovine serum (FBS) and antibiotics (peni-
cillin-streptomycin) at 37 °C in a humid atmosphere at
5% CO2. Parasites invaded the cells and replicated intra-
cellularly as amastigotes, after 48–72 h; amastigotes
transformed back to trypomastigotes and lysed host
cells. The infective trypomastigotes were separated from
cellular debris by low speed centrifugation (500× g).
From the supernatant, the parasites were isolated by
centrifugation at 3500× g, suspended in RPMI media
(without FBS, 1% antibiotics; RPMI 1640, Biological In-
dustries Ltd., Kibbutz Beit Haemek, Israel) and quanti-
fied in a Neubauer Chamber [14, 15].
HPE infection
HPE were obtained from healthy mothers with uncom-
plicated pregnancies by cesarean delivery. Placentas were
processed in a class II laminar flow hood immediately
after delivery. The maternal and fetal surfaces were dis-
carded and villous tissue was obtained from the central
part of the cotyledons. The dissected explants were
washed with sterile PBS in order to get rid of the blood
and co-cultivated with T. cruzi trypomastigotes in serum
free RPMI media. HPE were challenged with 105 or 106
parasites/ml, since these concentrations have been pro-
posed to correlate with low or high parasitaemia, re-
spectively [16]. For validation experiments, LPS (10 ng/
ml) was used as positive control. After 2 or 24 h of
infection (in order to study early and late placental re-
sponses [16–18], explants were collected in RNA later
solution (Thermo Fisher Scientific, Waltham, Massachu-
setts, USA), stored at 4 °C for 24 h and at -80 °C for pos-
terior RNA isolation [19].
RNA purification and microarray experiment
Total RNA was isolated with a Purelink RNA isolation
kit (Thermo Fisher Scientific) according to the manufac-
turer’s instructions. RNA integrity was analyzed with a
Bioanalyzer 2100 (Agilent Technologies, Santa Clara,
California, USA) obtaining RNA integrity numbers
(RIN) above 8 for all samples (on a scale based on an
rRNA 28S/18S ratio where a RIN of 1 corresponds to a
totally degraded RNA and 10 to a totally non-degraded
RNA). RNA concentration was quantified by spectropho-
tometry (Nanodrop, Thermo Fisher Scientific). One hun-
dred nanograms of total RNA was reverse-transcribed
into cDNA, then transcribed to cRNA and Cy3-labeled
with a Low Input Quick Amp-One Color Labeling Kit
(Agilent Technologies). The labeled cRNA was purified
with an illustra RNAspin Mini Isolation Kit (GE Health-
care, Little Chalfont, UK) and the total yield was measured
with a Qubit RNA HS Kit (Thermo Fisher Scientific).
Hybridization, washing, assembling of the chips, and scan-
ning were performed according to the manufacturers’ in-
structions. Briefly, labeled samples were hybridized with
SurePrint G3 Human GE 8x60K chips for 17 h at 60 °C in
an Agilent hybridization oven at 10× rpm. Posterior wash-
ing, stabilization and drying procedures were performed
according to Agilent’s Low Input Quick Amp Labeling Kit
instructions [10].
Data analysis
Chips were scanned with an Agilent microarray scanner
G2565BA; the software Agilent Feature Extraction (ver-
sion 9.5.1), was used for quality control, data filtering and
data normalization. Extracted data from the SurePrintG3
8x60K chips were analyzed using GeneSpring GX 13.0
software. Genes showing a 2-fold change in their expres-
sion (or more) with P ≤ 0.05 were considered differentially
expressed using ANOVA and Benjamini-Hochberg false
discovery rate correction for multiple testing. Analysis of
interaction networks between upregulated genes in each
experimental group was performed with Cytoscape net-
work visualization and integration software and GeneMa-
nia open-source gene function prediction service plug-in
(http://www.genemania.org/) and visualized by the corre-
sponding Cytoscape software version 3.0.2 plug-ins [20]
The weighting of the network attributes was set to Gene
Ontology (GO)-based weighting for biological processes.
Gene set enrichment analysis (GSEA) was performed with
GSEA 3.0 software (Broad Institute, Cambridge, Massa-
chussets, USA) [21]. Each gene set permutation was
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performed 1000 times, analyses were based on the GO
pathways database (http://geneontology.org/) [22] and a
normalized enrichment score (NES) was obtained for each
gene set. An enrichment map from data obtained with
GSEA was generated with the Enrichment Map plug-in
for Cytoscape 3.0 [23]. NES and false discovery rate
(FDR) q-value were considered as parameters for the
analysis. The NES value allows the comparison of ana-
lysis results across gene sets because it considers differ-
ences in gene sets sizes corrected by the size of the
expression dataset; the FDR represents the estimated
probability that a gene set with a given NES represents
a false positive finding [22].
RT-qPCR
One hundred picograms of total RNA was retro-transcribed
to cDNA using an M-MLV Reverse Transcriptase system
with Oligo(dT) primers (Thermo Fisher Scientific). For
real-time reactions, 10 μl of Sensifast qPCR Master Mix
(Bioline, London, UK) was mixed with 100 mM forward
Table 1 Sequences of primers used in RT-qPCR
Gene Forward primer Reverse primer
TLR2 TCGGAGTTCTCCCAGTGTTTG GCAGTGAAAGAGCAATGGGC
TLR4 GGTCAGACGGTGATAGCGAG TTTAGGGCCAAGTCTCCACG
TLR7 TCCATGCCATCAAGAAAGTTGA GTCTGTGCAGTCCACGATCA
TLR9 CAGCATGGGTTTCTGCCG GGGCAGTTCCACTTGAGGTT
NOD1 CCTGGTGGCCAAGTGATTGTA CCAAGCCTGCGATTCCCATA
NOD2 ATCCGGAGCCTGTACGAGAT CGCGCAAATACAGAGCCTTG
IL-1β CTTCGAGGCACAAGGCACAA CTGGAAGGAGCACTTCATCTGT
IL6 ACCCCCAATAAATATAGGACTGGA CGAAGGCGCTTGTGGAGAA
IL-12α GCTCCAGAAGGCCAGACAAA GCCAGAGCCTAAGACCTCAC
IFN-ɣ TGGAAAGAGGAGAGTGACAGA CTGTTTTAGCTGCTGGCGAC
IL-10 CGAGATGCCTTCAGCAGAGT GGCAACCCAGGTAACCCTTA
TGFβ TACCTGAACCCGTGTTGCTC CCGGTAGTGAACCCGTTGAT
IL-17 TGGAATCTCCACCGCAATGA GCTGGATGGGGACAGAGTTC
GAPDH AACAGCGACACCCACTCCTC GGAGGGGAGATTCAGTGTGGT
Fig. 1 Differential gene expression in Trypanosoma cruzi infected HPCVE at 2 and 24 h compared to not-infected control samples. HPCVE were
challenged with 105 (a) or 106 (b) trypomastigotes/ml. Blue bars indicate downregulated genes and red bars indicate upregulated genes. Inset
table shows the number of differentially expressed genes for each condition. (≥ 2-fold, P ≤ 0.05)
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Table 2 Upregulated and downregulated genes with fold change (FC) ≥ 20 at 2 and 24 h post-infection
Gene ID Description FC Gene ID Description FC
2 h
Upregulated 105 trypomastigotes Downregulated 105 trypomastigotes
LDOC1 Leucine zipper,
downregulated in cancer 1
71.43 SLC9B1 Solute carrier family 9,
subfamily B (NHA1, cation
proton antiporter 1),
member 1
65.64
ADAM12 ADAM metallopeptidase
domain 12
54.99 LBP Lipopolysaccharide binding
protein
60.23
PNMT Phenylethanolamine N-
methyltransferase
51.74 MEDAG Mesenteric estrogen-
dependent adipogenesis
52.12
ADORA3 Adenosine A3 receptor 48.44 SYT1 Synaptotagmin I 49.30
GH2 Growth hormone 2 44.96 RGS7BP Regulator of G-protein signal-
ing 7 binding protein
49.08
PCDHB13 Protocadherin beta 13 44.71 MT1H Metallothionein 1H 47.18
CXCL9 Chemokine (C-X-C motif)
ligand 9
26.61 CAPN8 Calpain 8 46.86
TLR7 Toll-like receptor 7 23.52 DCD Dermcidin 42.36
TLR8 Toll-like receptor 8 21.74 HTR5A 5-hydroxytryptamine
(serotonin) receptor 5A, G
protein-coupled
42.25
CD46 CD46 molecule,
complement regulatory
protein
21.48 KALRN Kalirin, RhoGEF kinase 42.01
C1QTNF3 C1q and tumor necrosis
factor related protein 3
21.41 CDH18 Cadherin 18, type 2 35.52
Upregulated 106 trypomastigotes Downregulated 106 trypomastigotes
LOC101060810 Zinc finger protein 98-like 68.80 SNRPG Small nuclear
ribonucleoprotein
polypeptide G
73.40
LMOD1 Leiomodin 1 (smooth
muscle)
62.19 TUBA1C Tubulin, alpha 1c 71.97
SPIN4 Spindlin family, member
4
53.45 TSC22D1 TSC22 domain family,
member 1
71.15
LINC00551 Long intergenic non-
protein coding RNA 551
52.98 CD14 CD14 molecule 70.98
PSG3 Pregnancy specific beta-
1-glycoprotein 3
47.68 MBNL2 Muscleblind-like splicing
regulator 2
64.74
PSG8 Pregnancy specific beta-
1-glycoprotein 8
45.17 FUT3 Fucosyltransferase 3
(galactoside 3(4)-L-
fucosyltransferase. Lewis
blood group)
63.73
PSPHP1 Phosphoserine
phosphatase pseudogene
1
44.87 GCGR Glucagon receptor 62.52
PSG1 Pregnancy specific beta-
1-glycoprotein 1
42.74 IL6 Interleukin 6 (interferon,
beta 2)
62.25
PCDHB13 Protocadherin beta 13 41.77 NOG Noggin 60.99
HULC Hepatocellular carcinoma
upregulated long non-
coding RNA
40.94 SBSN Suprabasin 60.01
ADAMTSL3 ADAMTS-like 3 34.70 FAM89A Family with sequence
similarity 89, member A
57.57
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and reverse primers and 2 μl of cDNA. Samples were
analyzed in an ABI 7300 real-time PCR system (Applied
Biosystems) with an initial step of 3 minutes at 95°C for
polymerase activation, followed by 40 cycles at 95°C for
5 seconds for denaturation, and 60°C for 15 seconds for
annealing/extension.333. Results were analyzed against
human GAPDH as a housekeeping gene and expressed
using the ΔΔCT method (Pfaffl, 2001). The sequences
Table 2 Upregulated and downregulated genes with fold change (FC) ≥ 20 at 2 and 24 h post-infection (Continued)
Gene ID Description FC Gene ID Description FC
24 h
Upregulated 105 trypomatigotes Downregulated 105 trypomastigotes
GCGR Glucagon receptor 26.78 GEMIN2 Gem (nuclear organelle)
associated protein 2
66.26
CHRDL2 Chordin-like 2 26.46 GUCA1A Guanylate cyclase activator
1A (retina)
50.37
TAC3 Tachykinin 3 23.82 LOC340515 Uncharacterized LOC340515 47.71
STC1 Stanniocalcin 1 21.80 LINC00200 Long intergenic non-protein
coding RNA 200
42.88
SLC43A3 Solute carrier family 43,
member 3
21.60 FAM182B Family with sequence
similarity 182, member B
41.35
PENK Proenkephalin 21.06 SEC14L4 SEC14-like 4 (S. cerevisiae) 38.81
SLC44A4 Solute carrier family 44,
member 4
21.02 CLEC6A C-type lectin domain family
6, member A
38.42
HLA-DQB1 Major histocompatibility
complex, class II, DQ
beta 1
20.99 SNORA65 Small nucleolar RNA, H/ACA
box 65
36.94
ANTXR1 Anthrax toxin receptor 1 20.21 LOC541473 FK506 binding protein 6,
36kDa pseudogene
36.81
SBSN Suprabasin 20.18 AKR7L Aldo-keto reductase family 7-
like
36.51
Upregulated 106 trypomastigotes Downregulated 106 trypomastigotes
MMP10 Matrix metallopeptidase
10 (stromelysin 2)
105.67 DNMT3L DNA (cytosine-5-)
-methyltransferase 3-like
63.39
CSH2 Chorionic
somatomammotropin
hormone 2
68.94 KLRG2 Killer cell lectin-like receptor
subfamily G, member 2
46.45
GH2 Growth hormone 2 68.66 MS4A6A Membrane-spanning
4-domains. subfamily A,
member 6A
40.49
CCL20 Chemokine (C-C motif)
ligand 20
58.87 TMEM45B Transmembrane protein 45B 40.27
ENO2 Enolase 2 (gamma,
neuronal)
53.70 IGFBP1 Insulin-like growth factor
binding protein 1
39.99
SOD2 Superoxide dismutase 2,
mitochondrial
53.42 PSPHP1 Phosphoserine phosphatase
pseudogene 1
39.83
PCDHB13 Protocadherin beta 13 53.33 TPTE2P3 Transmembrane
phosphoinositide 3-
phosphatase and Tensin
homolog 2 pseudogene 3
39.87
SELE Selectin E 52.93 MNDA myeloid cell nuclear
differentiation antigen
38.99
ABO ABO blood group
(transferase A, alpha 1-3-
N-acetylgalactosaminyl-
transferase; transferase B,
alpha 1-3-
galactosyltransferase)
51.78 FGF14-AS2 FGF14 antisense RNA 2 38.98
STC1 Stanniocalcin 1 51.40 PTX3 Pentraxin 3, long 38.59
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of primers can be found in Table 1. The results were
expressed as the mean ± SD. The significance of differ-
ences was evaluated using ANOVA followed by Dun-
nett’s post-hoc test as indicated.
Results
Trypanosoma cruzi changes the gene expression profile in
HPE
The effect of the parasite on placental tissue was assayed
in HPE after challenges with a low (105 parasites/ml) or
a high (106 parasites/ml) concentration of trypomasti-
gotes for 2 or 24 h.
Total RNA extracted from infected and non-infected
control HPE, was labeled and hybridized to a Human GE
60K Microarray, which allows the evaluation of the gene
expression profile of 26,083 different human genes. Genes
showing at least a 2-fold change in their expression and a
95% probability of being differentially expressed (P ≤ 0.05)
were significantly regulated during parasite challenge.
Figure 1 shows the total number of significant differentially
expressed genes between infected and non-infected control
HPE. A low parasite concentration induces the downregu-
lation of 431 and 1474 genes as well as the upregulation of
210 and 469 genes after 2 and 24 h of parasite challenge,
respectively (Fig. 1a). After a high parasite concentration
challenge, 157 and 722 genes were downregulated, and 342
and 454 were upregulated after 2 and 24 h, respectively
(Fig. 1b). Major changes occurred after 24 h of parasite
challenge with the lowest parasite concentration. A selec-
tion of the most upregulated and downregulated genes
(fold change range between 34.70 and 71.43) is shown in
Table 2. Among the most upregulated genes are those in-
volved in immune response such as CXCL9, TLR-7, TLR-8,
CD46, C1qTNF3, HLA-DQB1 and CCL20; genes involved
in extracellular matrix (ECM) remodeling (ADAM12,
ADAMTSL3, MMP10) and related to pregnancy. The list
of most downregulated genes also includes genes related to
immunity such as LBP, CD14, DCD and IL-6.
The Venn diagrams in Fig. 2a show that 19 genes are
upregulated in the four different experimental conditions
compared to control non-infected samples, which are also
shown in the corresponding heatmap (Fig. 2b) listed in
Table 3. Contrarily, only 5 genes are downregulated in the
same conditions (Fig. 3a, b), which are listed in Table 3.
Most of the upregulated genes are related to pregnancy
processes.
Trypanosoma cruzi alters a wide range of biological
processes in HPE
GO and pathway analysis were performed using Gene-
SpringGX 13.0 software (Agilent Technologies), compar-
ing the different experimental conditions described above.
Our results indicate that a wide range of biological pro-
cesses are altered at the different conditions in presence of
the parasite (Table 4). The different biological processes
detected include immune response, pregnancy related
processes and signaling. In order to understand the rela-
tionships between those biological processes, we per-
formed a GSEA analysis of gene sets at different times and
Fig. 2 Venn diagrams comparing common differentially upregulated genes. HPCVE were incubated for 2 and 24 h with 105 or 106 T. cruzi
trypomastigotes/ml. All samples were compared to the respective uninfected control. The diagram in a shows the upregulated genes at both
parasite concentrations and incubation times, b corresponds to the heatmap of the differentially expressed genes in the central intersection
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parasite load challenges. We analyzed biological processes
pathways based on gene ontology results (Fig. 4). The big-
gest cluster is composed of pathways related with immune
response, followed by development morphogenesis cluster,
regulation of metabolic processes and signal transduction
genes, metabolic processes, homeostasis, response to
stimulus, cell death and endocytosis (Fig. 4).
Several gene sets grouped within the main cluster (im-
mune response), are enriched at 2 or 24 h post-infection
after parasite challenges of 105 trypomastigotes/ml but
not of 106 parasites. Thus, immune system process path-
ways are positively regulated against 105 parasites at 2 h
(NES: 1.57; FDR q-value = 0.0013) and 24 h (NES: 2.75;
FDR q-value = 0.0018), downregulated with 106 trypo-
mastigotes/ml at 2 h (NES: -2.1; FDR q-value = 0.0087)
but not at 24 h (NES: 1.44; FDR q-value = 0.18).
Regulation of immune response is positively regulated
with 105 parasites at 2 h (NES: 1,50; FDR q-value =
0.022) and 24 h (NES: 1.98; FDR q-value = 0.01) but
negatively with 106 parasites at 2 h (NES: -1,77; FDR
q-value = 0.067) and without significant changes at 24 h
(NES: -0,83; FDR q-value not significant).
Gene Ontology process regulation of cytokine produc-
tion is upregulated 2 h post-infection (NES: 1.36; FDR
q-value = 0.023) but not in the other experimental
groups. The inflammatory response pathway is upregu-
lated 24 h post-infection against 105 trypomastigotes
(NES: 1.65; FDR q-value = 0.049) but downregulated
with 106 parasites 2 h post-infection (NES: 1.99; FDR
q-value = 0.023). Amongst the changes of pathways re-
lated to other processes, it can be highlighted the upreg-
ulation of cell proliferation pathway 24 h post-infection
Table 3 Upregulated and downregulated genes in the four different experimental conditions compared to control non-
infected samples
Gene symbol Description
Upregulated genes
MAMDC2 Homo sapiens MAM domain containing 2 (MAMDC2), mRNA [NM_153267]
CSH1 Homo sapiens chorionic somatomammotropin hormone 1 (placental lactogen) (CSH1), mRNA [NM_001317]
SEMA3B Homo sapiens sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
(SEMA3B), transcript variant 1, mRNA [NM_004636]
FRZB Homo sapiens frizzled-related protein (FRZB), mRNA [NM_001463]
PSG2 Homo sapiens pregnancy specific beta-1-glycoprotein 2 (PSG2), mRNA [NM_031246]
PSG8 Homo sapiens pregnancy specific beta-1-glycoprotein 8 (PSG8), transcript variant 1, mRNA [NM_182707]
STEAP4 Homo sapiens STEAP family member 4 (STEAP4), transcript variant 2, mRNA [NM_001205315]
Uncharacterized protein [Source: UniProtKB/TrEMBL; Acc: B8ZZY5] [ENST00000409490]
PSG6 Homo sapiens pregnancy specific beta-1-glycoprotein 6 (PSG6), transcript variant 1, mRNA [NM_002782]
CTAG1A Homo sapiens cancer/testis antigen 1A (CTAG1A), mRNA [NM_139250]
ERV3-1 Homo sapiens endogenous retrovirus group 3, member 1 (ERV3-1), mRNA [NM_001007253]
GH2 Homo sapiens growth hormone 2 (GH2), transcript variant 3, mRNA [NM_022558]
PSG8 Homo sapiens pregnancy specific beta-1-glycoprotein 8 (PSG8), transcript variant 1, mRNA [NM_182707]
ABO ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-
galactosyltransferase) [Source: HGNC Symbol; Acc:79] [ENST00000319878]
CD200 Homo sapiens CD200 molecule (CD200), transcript variant 2, mRNA [NM_001004196]
CRH Homo sapiens corticotropin releasing hormone (CRH), mRNA [NM_000756]
CSH2 Homo sapiens chorionic somatomammotropin hormone 2 (CSH2), transcript variant 2, mRNA [NM_022644]
PSG1 Homo sapiens pregnancy specific beta-1-glycoprotein 1 (PSG1), transcript variant 1, mRNA [NM_006905]
ADAM12 Homo sapiens ADAM metallopeptidase domain 12 (ADAM12), transcript variant 2, mRNA [NM_021641]
Downregulated genes
SALL4 Homo sapiens spalt-like transcription factor 4 (SALL4), mRNA [NM_020436]
LINC00200 Homo sapiens long intergenic non-protein coding RNA 200 (LINC00200), long non-coding RNA [NR_015376]
NPPB Homo sapiens natriuretic peptide B (NPPB), mRNA [NM_002521]
TAS2R4 Homo sapiens taste receptor, type 2, member 4 (TAS2R4), mRNA [NM_016944]
STRIP2 Homo sapiens striatin interacting protein 2 (STRIP2), transcript variant 1, mRNA [NM_020704]
FRZB Homo sapiens frizzled-related protein (FRZB), mRNA [NM_001463]
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(NES: 2.18; FDR q-value = 0.003) and cellular response
to hormone stimulus (2 h 105 Trypos NES: 2.53; FDR
q-value = 0.005).
To understand the nature of the interaction between up-
regulated or downregulated genes, we performed a gene
interaction analysis using the GeneMANIA plug-in for
Cytoscape 3.0 software [24, 25]. For each experimental con-
dition, we analyzed co-expression, co-localization, physical
interactions, genetic interactions shared protein domains
and pathways amongst all the differentially expressed genes
(Fc ≥ 2) in both upregulated or downregulated gene lists.
The relative weight of each process between all interacting
genes is depicted in Table 5. In all experimental conditions,
co-expression (a category where two genes have similar
expression levels) is the predominating interaction,
co-localization (genes expressed in the same tissue) the sec-
ond in the upregulated conditions; however, in downregu-
lated groups physical interactions (when two gene products
are found to interact in protein-protein interaction studies)
is the second most common interaction. Shared protein do-
mains, genetic and pathways interaction represent marginal
interactions in all groups. A circular layout of the interaction
network for each is shown in Additional file 1: Figure S1.
Trypanosoma cruzi induces differential expression of
pathogen pattern recognition receptors in HPE
Based on the results of the microarray analysis showing an
activation of local immune processes, we decided to validate
by RT-qPCR PRR activation and cytokine production. Ex-
plants were co-incubated with 105 T. cruzi trypomastigotes
for 2 h and the expression of Toll-like receptors (TLRs) and
NOD-like receptors (NLRs) was assayed. Trypanosoma
cruzi trypomastigotes induce statistically significant increases
of TLR-2 (96.13 ± 61.6%; F(2, 9) = 5.409; P ≤ 0.01, Fig. 5a),
TLR-4 (47.56 ± 27.99%; F(2, 45) = 2.173; P ≤ 0.0001, Fig. 5b),
TLR-7 (57.29 ± 24.59%; F(2, 2) = 6.048; P ≤ 0.05, Fig. 5c) and
TLR-9 (61.56 ± 5.11%; F(2, 6) = 1.630; P ≤ 0.01, Fig. 5d) ex-
pression compared to non-infected HPE. However, T. cruzi
does not increase significantly NOD-1 and NOD-2 recep-
tors (Fig. 5d, e).
Trypanosoma cruzi increases pro-inflammatory and
immune-modulating cytokines in HPE
HPE were co-incubated with 105 T. cruzi trypomastigotes
for 2 h as well as in the presence and absence of LPS as
positive controls. T. cruzi induces significant increases of the
pro-inflammatory cytokines IL-1β (5542.55 ± 1090.11%; F(2,
19) = 64.91; P ≤ 0.0001, Fig. 6a), IL-6 (94.70 ± 40.38%; F(2, 15)
= 8.849; P ≤ 0.01, Fig. 6b), IL-12α (77.08 ± 33.01%; F(2, 19) =
64.91; F(2, 15) = 16.13; P ≤ 0.01, Fig. 6c), IFNγ (329.29 ±
162.22%; F(2, 17) = 7.729; P ≤ 0.05, Fig. 6d) and of the
immune-modulating cytokines IL-10 (303.34 ± 104.28%; F(2,
20) = 14.87; P ≤ 0.001, Fig. 6e) and TGF β (329.29 ±
162.22%; F(2, 11) = 1.684; P ≤ 0.05, Fig. 6f) but not of IL-17
(Fig. 6g).
Discussion
The interaction between the host and pathogens, including
T. cruzi, is the most important factor in determining
whether an infection is successful. Host-parasite interaction
Fig. 3 Venn diagrams comparing common differentially downregulated genes. HPCVE were incubated for 2 and 24 h with 105 or 106 T. cruzi
trypomastigotes/ml. All samples were compared to the respective uninfected control. The diagram in a shows the downregulated genes at both
parasite concentrations and incubation times, b corresponds to the heatmap of the differentially expressed genes in the central intersection
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includes invasion of the host through primary barriers (such
as the placental barrier), evasion of host defenses, pathogen
replication in the host, and immunological capacity of the
host to control or eliminate the pathogen [26]. Importantly,
infected organisms are capable of sensing the intrusion by
pathogens and react by triggering host defenses [17, 26]. On
the other hand, the parasite is equipped with multiple tools
to establish a long-term relationship with the infected host.
Tissue infection in particular is relevant during disease pro-
gression. The presence of the parasite provokes tissue dam-
age as well as immune and reparatory responses, which
can lead to fibrosis and tissue dysfunction as observed in
chagasic cardiomyopathy [27]. Considering the temporary
existence of the placenta, the effect on parasite infection
on this particular tissue is relevant to understand the phys-
iopathology of congenital transmission in order to obtain
tools for diagnosis, prognosis and treatment of the disease.
Previous studies about transcriptomics related to T. cruzi
and Chagas disease have been focused on a single type cell
response [10, 28] or on tissues or organs in animal models
[24, 29] but not on human tissues. Here, we describe for the
first time, the transcriptomics of an ex vivo human placental
tissue model in response to challenges with the parasite.
As expected, T. cruzi modifies an ample range of bio-
logical processes during tissue invasion and infection. As
described before, the parasite dramatically changes the gene
expression in single cells [10]. However, in tissue and organ
samples a more complex change in gene expression can be
expected since they are composed of different cell types or
tissues. For instance, in HPE epithelial cells derived from
the trophoblast and fetal capillaries as well as fibroblasts
and macrophages in the fetal connective tissue can be
found, between others [3]. In addition, ECM components,
that are synthetized by the resident cells are also present in
tissue and organ samples [18, 19]. Similar results have been
obtained in animal models, where important changes in
murine myocardium metabolic pathways [29] and in mur-
ine placental response [24] are described. The increase of
Table 4 Biological processes predicted to be modulated during T. cruzi infection
GO Accession GO term No. of genes/condition
105 2 h 106 2 h 105 24 h 106 24 h
Upregulated biological processes
GO:0022414 Reproductive process 45 42 45 114
GO:0032501|GO:0050874 Multicellular organismal process 191 189 326 550
GO:0050896|GO:0051869 Response to stimulus 208 196 728 623
GO:0051704|GO:0051706 Multi-organism process 56 58 204 197
GO:0065007 Biological regulation 269 255 977 836
GO:0002376 Immune system process 39 36 236 215
GO:0009987|GO:0008151|GO:0050875 Cellular process 346 334 1161 987
GO:0022610 Biological adhesion 35 23 134 99
GO:0023052|GO:0023046 Signaling 141 132 543 464
GO:0044699 Single-organism process 342 0 1125 972
GO:0051179 Localization 125 0 415 372
GO:0071840|GO:0071841 Cellular component organization or biogenesis 105 0 427 307
GO:0008152 Metabolic process 238 0 0 629
GO:0032502 Developmental process 144 0 0 434
Downregulated biological processes
GO:0009987|GO:0008151|GO:0050875 Cellular processes 902 681 937 648
GO:0023052|GO:0023046 Signaling 388 0 376 0
GO:0032501|GO:0050874 Multicellular organismal process 516 0 490 0
GO:0044699 Single-organism processes 903 620 880 615
GO:0050896|GO:0051869 Response to stimulus 547 371 507 328
GO:0065007 Biological regulation 697 505 734 487
GO:0071840|GO:0071841 Cellular component organization or biogenesis 0 240 0 248
GO:0022414 Reproductive processes 0 0 106 0
GO:0051179 Localization 0 0 275 0
GO:0051704|GO:0051706 Multi-organism processes 0 0 123 0
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gene expression of proteases involved in ECM-remodeling
(Table 2) is in concordance with our previous results show-
ing that the parasite increased expression and activity of
matrix metalloproteases (MMP-2 and MMP-9) in human
placenta [19]. The profound changes in genes involved in
signaling agrees with numerous previous studies that
showed that T. cruzi activates or inhibits several signal
transduction pathways [14, 28, 30].
The effect of T. cruzi on the immune system responses
are particularly relevant since they are our main defense
against the pathogen. The parasite dramatically changes
host genes involved in the immune response. The
expression of an important number of genes of innate
immunity is increased. Thus, genes related to comple-
ment regulation and function such as CD46 and C1q are
upregulated. We have previously shown, that during ex
Fig. 4 Enrichment map of gene sets of biological processes pathways. HPCVE were incubated for 2 and 24 h with 105 or 106 T. cruzi trypomastigotes/ml.
Genes with fold changes ≥ 2 (P ≤ 0.05) were considered for the analysis. Gene set analysis (GSEA) was performed based in pathways from GO biological
processes. Nodes correspond to gene sets and connecting lines to overlapping member genes between nodes. Divided circles represent predicted
pathways, each segment of the circle represents a different experimental group according to attached legend and colors depict upregulated (red) or
downregulated (blue) genes. Clusters grouped by biological function were manually labeled
Table 5 Relative weight of gene interactions in T. cruzi-infected HPE
Network group 2 h/105
Up
2 h/105
Down
2 h/106
Up
2 h/106
Down
24 h/105
Up
24 h/105
Down
24 h/106
Up
24 h/106
Down
Co-expression 72 61 64 42 75 66 75 75
Co-localization 13 7 18 9 11 6 14 3
Physical interactions 7 14 11 31 6 17 6 9
Genetic interactions 4 0 2 4 3 0 0 1
Shared protein domains 0 1 1 3 0 1 1 0
Pathway 0 1 1 3 0 0 1 7
Others 4 16 3 8 5 10 3 5
Abbreviations: Up, upregulated; Down, downregulated; H, hours of HPE incubation with the parasite; 105, challenge with 105 parasites/ml; 106, challenge with 106
parasites/ml
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Fig. 6 Trypanosoma cruzi increases pro-inflammatory and immune-modulating cytokines in HPE. HPE were co-incubated with 105 T. cruzi
trypomastigotes/ml for 2 h as well as in the presence and absence of LPS as positive control. Expression of IL-1β (a), IL-6 (b), IL-12α (c), IFNγ (d),
IL-10 (e), TGF β (f) and IL-17 (g) was assayed. Samples were processed for RT-qPCR. The sequences of primers can be found in Table 1. The
significance of differences was evaluated using Student’s t-tests for paired data. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001
Fig. 5 Trypanosoma cruzi induce differential expression of pathogen pattern recognition receptors in HPE. Explants were co-incubated with 105 T.
cruzi trypomastigotes/ml for 2 h and the expression of TLR-2 (a), TLR-4 (b), TLR-7 (c), TLR-9 (d), NOD-1 (e) and NOD-2 (f) were assayed. Samples
were processed for RT-qPCR. The sequences of primers can be found in Table 1. The significance of differences was evaluated using Student’s t-
tests for paired data. *P ≤ 0.05, **P ≤ 0.01, ****P ≤ 0.0001
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vivo infection of HPE, T. cruzi calreticulin (TcCRT) acts
as a virulence factor since it binds maternal classical
complement component C1q and increases parasite in-
fectivity [31]. On the other hand, TLRs are also in-
creased, particularly TLR-7 and TLR-8 which are
increased over 20-fold. The validation experiments show
that both mentioned TLRs as well as TLR-2, TLR-4 and
TLR-9 are significantly increased (Fig. 5). However,
TLR-2, the TLR whose inhibition increases parasite in-
fection in HPE as well as parasite-induced tissue damage
[17] showed no significant increase in the microarray
analysis (Additional file 1: Figure S1).
A similar contradictory result was obtained with IL-6; a
high parasite concentration decreases the expression of this
cytokine more than 60-fold (Table 2). However, a low para-
site concentration does not change IL-6 expression (Add-
itional file 1: Figure S1). However, our RT-qPCR data show
a significant increase of IL-6 (Fig. 5) that is in concordance
with the increase of IL-6 protein in the culture media of
HPE after parasite challenge in the same condition [17],
suggesting regulation at post-transcriptional levels.
Another important group of genes that change their ex-
pression are those related to pregnancy. Most of the 19
upregulated genes in the four different experimental con-
ditions compared to control samples are related to preg-
nancy processes (Table 3) and to the maintenance and
development of the fetus such as pregnancy specific
beta-1-glycoproteins, GH2 (growth hormone 2), CSH1
and CSH2 (chorionic somatomammotropin hormone 1
and 2). Given that the placenta is the sole interface be-
tween mother and fetus and that this organ not only pro-
tects the fetus from infection but also regulates important
metabolic and other physiological processes [32], it ap-
pears easily explainable that different pregnancy related
processes are affected.
Conclusions
Trypanosoma cruzi induces strong changes in genes in-
volved in a wide range of pathways, especially those in-
volved in immune response against infections.
Additional file
Additional file 1: Figure S1. Interaction networks in differentially
expressed genes from each experimental group. HPCVE were incubated
during 2 and 24 h with 105 or 106 T. cruzi trypomastigotes. Interaction
networks from differentially expressed genes (FC ≥ 2) compared with
uninfected control with GeneMANIA function prediction service plug-in in
Cytoscape software. Co-expression, co-localization, physical interac-
tions, genetic interactions shared protein domains and pathways are
shown and each color represents specific interactions according to
legend. (PDF 707 kb)
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